You own the code. Do you own the innovation?

01 · The distinction

An assignment establishes rights. It does not establish capability.

Appendix Innovator Founder requires a substantive founder contribution and an innovative, viable and scalable venture. The endorsing-body guidance expects the innovation to be central to the proposition and primarily delivered within the business. Those are different inquiries from legal title to a software asset.

A useful preparation exercise is to separate 3 questions: who conceived the distinctive solution, who made the decisions needed to develop it, and who can now maintain and improve it? An assignment clause addresses none of those questions by itself. It may be essential commercially while carrying limited weight on the underlying endorsement issue.

A nontechnical founder is not automatically unsuitable. Sector expertise, product design and a substantive commercial role can matter. The evidence must nevertheless explain how the founding team can deliver the particular innovation it claims. Describing a future technical hire as an existing capability weakens that explanation.

02 · The operating model

Break the development brief into decisions, not job titles.

A contract labelled software development can cover routine implementation or the entire intellectual undertaking. Ask who defines the novel process, chooses the architecture, sets the evaluation method, investigates failures and decides which trade-offs are acceptable. The distribution of those decisions reveals more than the supplier's job title.

For example, a venture may have developed a specialist method internally and commission an interface around it. Another may ask an agency to identify the method, build the system and decide whether it works. These are illustrative operating models, not predetermined endorsement outcomes. The second raises a much more substantial dependence problem.

Prepare a responsibility schedule showing completed work, current responsibilities and unfilled roles. Support it with actual design records, prototypes, decision logs and the team's relevant experience. A polished organisation chart should not conceal that the agency is the only party capable of explaining the product.

03 · The contract

Read the ownership clause alongside the exclusions.

A promise to assign deliverables may sit beside a broad exclusion for the supplier's existing technology. Third party components, licences and reusable modules can further limit what the venture receives. The correct legal analysis depends on the agreement and applicable law. Do not assume that payment transfers every right needed to operate the product.

For immigration preparation, the practical concern is whether the business plan describes rights and capabilities the company actually has. Check access to source repositories, technical documentation, deployment credentials, data, testing records and any restrictions on modification or transfer. Those documents can expose a material gap between the pitch and the operating position.

An IP specialist may need to address ownership and licensing; immigration counsel must then test the corrected position against the endorsement narrative. Neither exercise substitutes for the other. A stronger assignment cannot turn wholly outsourced innovation into internally delivered innovation.

04 · Continuity

Ask what happens if the agency stops tomorrow.

Can the team deploy a critical fix, investigate a customer complaint and assess the implications of a change to an external service? If every answer depends on purchasing another agency engagement, that dependence should appear in the operational and financial model.

An exit plan may require documentation, an effective handover and real internal technical leadership. These arrangements should be implemented where commercially appropriate, not merely listed as future intentions. An adviser available occasionally is not necessarily the person who will own production decisions every day.

The immigration significance is evidential: the venture must present an achievable plan with the resources available to it. The commercial significance is wider. A customer contract or investment round may bring obligations that a demonstration build was never designed to meet.

05 · The decision

Do not spend another development milestone to protect a weak route assumption.

Where internal innovation exists but is poorly documented, the next step may be evidence reconstruction from genuine records. Where the capability is missing, the company may need an operating change before endorsement is realistic. Where the business is essentially the purchase and resale of an agency product, a different immigration strategy may be more appropriate.

These are materially different recommendations. A founder should receive an assessment identifying which position the evidence supports, what needs to change and whether the change is feasible within the immigration timetable. No contractual or staffing change guarantees endorsement.

Bring the product specification, development agreement, ownership provisions, current demonstration, team commitments and permission expiry to that assessment. The question is whether further expenditure advances a credible venture and route, rather than simply making the existing application more expensive to abandon.

Practical questions.